|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 412 First Street, SE, Suite 3 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400660986-24
|
||||||||
|
6. House ID# 414350000
|
TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: G. David Mason |
Date | 1/17/2014 2:18:26 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Legislation and policies related to:
Physician/nurse practitioner reimbursement
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Adoption of recommendations of the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health
Draft legislation to repeal the Medicare sustainable growth rate and reform fee-for-service payment
Delay of the scheduled implementation of Medicare durable medical equipment documentation requirements
Medicare Shared Savings Program beneficiary assignment requirements
Medicare-Medicaid hospital conditions of participation
Draft legislation on admission of advanced practice registered nurses to hospital medical staff and granting of clinical privileges
Provisions of the 2013 Medicare fee schedule final regulations
Draft legislation to require states to recognize nurse practitioners as primary care case managers and as primary care providers in managed care plans
Draft legislation to extend Medicaid incentives to adopt electronic health records to nurse-managed health clinics
Evaluation of the Medicare Graduate Nurse Education demonstration
Medicare-Medicaid Program Integrity policies
Medicaid maintenance of effort requirements
Medicaid eligibility expansion and state options
Medicaid waiver application procedures
Medicaid per capita cap policy options
Medicare-Medicaid dual eligible coverage and demonstration
H.R. 351/S. 351 - Protecting Seniors Access to Medicare Act
H.R. 574 - Medicare Physician Payment Innovation Act
H.R. 1698 - Stabilize Medicaid and CHIP Coverage Act
H.R. 2504/S. 1332 - Home Health Care Planning Improvement Act
H.R. 2524/S. 1228 - Medicare Better Health Rewards Act
H.R. 2810 - Medicare Patient Access and Quality Improvement Act
H.R. 2817 - Protect Patient Access to Quality Health Professionals Act
H.R. 2986 - Protecting Access to Primary Care Act
S. 1143/H.R. 2810 - Protecting Access to Rural Therapy Services (PARTS) Act
S. 1758 - Quality Data, Quality Healthcare Act
S. 1871 - SGR Repeal and Medicare Beneficiary Access Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Legislation and policies relating to:
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Section 2706 of the ACA regarding provider non-discrimination
Health care coverage and payment options in tax reform discussions
Policies affecting nurse practitioner education and workforce
Definition of essential health benefits
Health information technology and electronic health records
Mental health services and violence prevention
Draft legislation on reauthorization of the National Quality Forum
H.R. 297/S. 1557 - Childrens Hospital GME Support Reauthorization Act
H.R. 628/S. 195 - Mental Health in Schools Act
H.R. 1249/S. 1756 - Common Sense Nutrition Disclosure Act
H.R. 1427 - Truth in Healthcare Marketing Act
H.R. 1947/H.R. 2642 - Federal Agriculture Reform and Risk Management (FARRM) Act
H.R. 2019 - Kids First Research Act
H.R. 2285 - Strategies to Address Antimicrobial Resistance Act
H.R. 2575 - Save American Workers Act
H.R. 2663/S. 1422 - To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings
H.R. 3102 - Nutrition Reform and Work Opportunity Act
H.R. 3147 - Food Labeling Modernization Act
H.R. 3304/S. 1197 - National Defense Authorization Act (Section 1725)
H.R. 3306 - Telehealth Enhancement Act
H.R. 3527 - Poison Center Network Act
H.R. 3717 - Helping Families in Mental Health Crisis Act
H.R. 3742 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act
S. 264/H.R. 1263 - Excellence in Mental Health Act
S. 689 - Mental Health Awareness and Improvement Act
S. 696 - Safe Chemicals Act
S. 744/H.R. 15 - Border Security, Economic Opportunity, and Immigration Modernization Act
S. 954 - Agriculture Reform, Food, and Jobs Act
S. 1009 - Chemical Safety Improvement Act
S. 1086 - Child Care and Development Block Grant Act
S. 1152 - Building a Health Care Workforce for the Future Act
S. 1417 - Newborn Screening Saves Lives Act
S. 1758 - Quality Data, Quality Healthcare Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Legislation and policies relating to:
Authorization and appropriations of Title VIII funding for nurse education and nurse workforce development programs in fiscal years 2014 and 2015
Title III funding for Nurse Managed Health Clinics
Appropriation of Title IV funding for the National Health Care Workforce Commission
Appropriation of funding for the Emergency Medical Services for Children program
Simpson-Bowles deficit reduction proposals
Impact of sequestration on the Health Resources and Services Administration (HRSA) and other non-defense discretionary spending
H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013
H.R. 3273 - Deficit Reduction and Economic Growth Working Group Act
H. Con. Res. 25 - Establishing the budget for fiscal year 2014
S. Con. Res. 8 - Setting forth the congressional budget for fiscal year 2014
S. 1284 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
H.J. Res. 59 - Continuing Appropriations Resolution, 2014
H.R. 2775 - Continuing Appropriations Act, 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Legislation and policies relating to:
FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance
H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug
H.R. 1919 - Safeguarding Americas Pharmaceuticals Act
S. 621 - Safe Prescribing Act
S. 959 - Pharmaceutical Compounding Quality and Accountability Act
H.R. 3089 - Compounding Clarity Act
H.R. 3204 - Drug Quality and Security Act (Public Law 113-54)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |